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Since bovine leukemia virus (BLV) replicates in B-lymphocytes, viral expression and production should respond to agents
activating these cells. We asked whether synthesis of BLV capsid (CA) protein and production of infectious virus would increase
when peripheral blood mononuclear cells (PBMCs) from infected sheep were stimulated in short-term culture with lipopolysaccha-
ride (LPS), a polyclonal activator of B-cells, and compared its effects with those of phytohemagglutinin (PHA), a lymphocyte
activator known to increase BLV expression. LPS treatment of PBMCs from asymptomatic sheep that had been infected for 1–
4 years increased the number of cells synthesizing CA protein, the amount of CA protein per cell, and the number of PBMCs
acting as infectious centers. LPS derived from several different microbes was effective. During the ensuing 4 years of asymptom-
atic infection, the number of PBMCs expressing virus under minimal stimulation increased for each animal. The ability of LPS
to recruit additional cells to express CA protein remained constant or decreased in magnitude, yet at the same time, lower
concentrations of LPS were required to elicit a maximal effect. This suggests that the cellular pathways affected by LPS are
endogenously more activated as infection progresses. PHA initially stimulated fewer cells to synthesize BLV CA protein than
LPS did although the amount of CA protein synthesized per cell was greater with PHA. As infection progressed, PHA surpassed
LPS in the numbers of PBMCs induced to express CA protein. This suggests that the cellular pathways affected by PHA become
more responsive to its effects as infection progresses. LPS increased CA expression early and transiently during culture whereas
the PHA-mediated increase continued to develop for several days. Thus, LPS increases BLV expression but does so differently
than PHA. Moreover, these longitudinal results show that the activation state of BLV-infected cells changes as asymptomatic
infection progresses. q 1996 Academic Press, Inc.
INTRODUCTION ular stomatitis virus (Schmidt and Woodland, 1990). On-
cogenic retroviruses have an additional need for host
Once the proviral genome of a retrovirus is integrated cell activation: integration of the provirus into the cellular
into the DNA of an infected cell, viral gene expression genome requires that the cell be cycling (reviewed by
is contingent on the cell’s capacity to transcribe and Roe et al., 1993). Proliferating lymphocytes are metaboli-
translate messenger RNA. Bovine leukemia virus (BLV) cally active, so BLV gene expression might be expected
and its close relatives, human T-cell leukemia virus to follow upon integration of the provirus and to occur
(HTLV) types I and II, replicate in lymphocytes, employing in tissues where lymphocyte activation and proliferation
the virally encoded regulatory proteins Tax and Rex to ordinarily take place.
modify the transcription of viral RNA and its availability Interestingly, most BLV- and HTLV-infected lympho-
for translation as well as to modify expression of host cytes that are released from lymphoid tissues into circu-
cell genes (reviewed by Green and Chen, 1994; Kettmann lating blood do not contain readily apparent viral gene
et al., 1994; Radke, 1994). Most lymphocytes are quies-
products. Rare cells containing viral transcripts can be
cent in vivo, maintaining low levels of RNA and protein
detected among freshly purified peripheral blood mono-
synthesis. After becoming activated by encountering anti-
nuclear cells (PBMCs) using in situ hybridization (Laga-
gen, lymphocytes develop an increased capacity for bio-
rias and Radke, 1989; Gessain et al., 1991; Radke et al.,
synthesis and become better vehicles for virus produc-
1992). Transcripts prepared from PBMCs obtained fromtion. Activation of B-lymphocytes to different extents, us-
the blood of infected individuals encode the Tax anding antiimmunoglobulin as surrogate antigen together
Rex proteins (Kinoshita et al., 1989; Gessain et al., 1991:with T-cell-derived lymphokines, has elegantly demon-
Jensen et al., 1991), products of additional open readingstrated that cells fully activated to proliferate and differen-
frames in the X region (Alexandersen et al., 1993;tiate are the best producers of the lytic rhabdovirus vesic-
Berneman et al., 1992), and structural proteins of the
virion (Haas et al., 1992). Whether these transcripts are
expressed together within the same rare cells or are1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (916) 752-8960. E-mail: klradke@ucdavis.edu. expressed differentially is unknown. Factors present in
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plasma of BLV-infected animals have been proposed to 2-year intervals. LPS did increase BLV production but
the responses of BLV-infected PBMCs to LPS and PHArepress viral gene expression (Zandomeni et al., 1992).
However, when PBMCs purified from the blood of in- changed as infection progressed.
fected animals are cultured, synthesis of viral RNA is
detectable in many cells within a few hours (Lagarias METHODS
and Radke, 1989). Polyadenylated viral transcripts are
Experimental animalsdetectable as soon as 30 min and the viral capsid (CA)
protein is synthesized in a few cells within 3 hr (Powers Sheep (mixed breed) had been infected with BLV for
and Radke, 1992). 1 to 4 years when this work began: 410 (1 year); 380,
B-lymphocytes are the predominant hosts for BLV in 407, 409, 468, 469 (3 years); 167 (4 years). Five animals
cattle and sheep (Paul et al., 1977; Kenyon and Piper, were initially injected when 2 to 10 weeks old with BLV
1977; Djilali et al., 1987; Aida et al., 1989; Schwartz et derived from persistently infected bat lung cells (Bat2
al., 1994), so polyclonal activators of B-cells would be clone 6) and sheep 380 was injected with blood from
expected to increase BLV production in culture. One such BLV-infected sheep 169 that had been infected with virus
agent, bacterial lipopolysaccharide (LPS), increases ex- from Bat2 clone 6 cells (Lagarias and Radke, 1990).
pression in B-cells of a number of endogenous retrovi- Sheep 410 was injected when 2 years old with BLV from
ruses including murine C-type viruses, mouse mammary Bat2 clone 6 cells (Radke et al., 1992).
tumor virus, and avian C-type viruses (reviewed by King
and Corley, 1990). However, LPS and other B-cell activa- Isolation and culture of PBMCs
tors such as dextran sulfate and antiimmunoglobulin
Blood was collected by jugular venipuncture intohave not been found to stimulate BLV expression (Chat-
acidic citrate–dextrose (Becton–Dickinson Vacutainers)terjee et al., 1985; Djilali et al., 1987; Levy et al., 1987;
to prepare PBMCs as described (Lagarias and Radke,Cornil et al., 1988). Rather, high concentrations (up to 50
1990). In brief, buffy coat cells were centrifuged over
mg/ml) of the T-cell mitogen phytohemagglutinin (PHA)
Histopaque-1077 (Sigma). PBMCs harvested from the in-have been shown to augment production of virions (Miller
terface were washed twice with Hanks’ balanced saltet al., 1969; Stock and Ferrer, 1972), synthesis of viral
solution and then resuspended in growth medium com-CA protein (Baliga and Ferrer, 1977; Chatterjee et al.,
posed of minimal Eagle’s medium (MEM) supplemented1985; Cornil et al., 1988), and viral surface glycoprotein
with 0.1 mM MEM nonessential amino acids, 2 mM(Djilali et al., 1987; Levy et al., 1987; Jensen et al., 1990).
L-glutamine, 100 U penicillin per milliliter, 100 mg strepto-Lower concentrations of PHA (1.25–5 mg/ml) are known
mycin per milliliter, and 5% heat-inactivated fetal bovineto increase viral transcription (Chatterjee et al., 1985;
serum. For immunocytochemical analysis, PBMCs wereLagarias and Radke, 1989). How PHA increases BLV ex-
cultured at 377 at a density of 5 1 105 cells per milliliter.pression is unclear. Evidence has been presented that
Lymphocyte activators were added to cultures at concen-PHA induces T-cells to produce soluble factors required
trations indicated for individual experiments. LPS wasby B-cells for synthesis of BLV proteins (Djilali et al.,
from Salmonella minnesota unless otherwise noted; all1987; Cornil et al., 1988). However, other results suggest
preparations were tissue culture grade (Sigma) and hadthat PHA can act directly on purified B-cells to increase
similar stimulation indices. Phytohemagglutinin-P (PHA-BLV expression (Chatterjee et al., 1985; Jensen et al.,
P; Difco Laboratories) was used in the initial cluster of1990).
tests; then, to avoid agglutination of residual erythro-When PBMCs from infected, asymptomatic sheep are
cytes, it was replaced with PHA-L (Sigma) after we deter-cultured for 8 hr in the presence of fetal bovine serum,
mined that 2.5 mg PHA-L per milliliter stimulated BLVa number of infected cells begin to transcribe BLV. When
expression as much as 5.0 mg PHA-P per milliliter.LPS is present, more cells transcribe BLV and the num-
ber of transcripts per cell increases (Lagarias and Radke, Infectious center assays
1989). LPS slightly accelerates transcription while coordi-
nately increasing the abundance of the three size classes BLV-producing PBMCs were detected by their ability
to induce late syncytia among F81 indicator cells. Briefly,of BLV transcripts that are templates for translation of
Gag/Pro/Pol, Env, and Tax/Rex proteins (Powers and PBMCs (2.5 1 105 or fewer) were cultured with sparsely
plated indicator cells either in growth medium containingRadke, 1992). We wanted to know whether the LPS-medi-
ated increase in BLV transcription extended to the syn- 1% methylcellulose as a semisolid matrix, which provides
a focal assay for infected PBMCs (Radke et al., 1992),thesis of the viral CA protein and the ability of PBMCs
to act as infectious centers, so we compared the effects or in 1 ml growth medium (Lagarias and Radke, 1990).
Coculture was for a standard period of 48 hr or for inter-of LPS on these measures of viral expression with those
of PHA, which has long been known to increase BLV vals specified in particular experiments. PBMCs were
then removed by careful washing with growth medium,expression. Here, we present results of a longitudinal
study in which three clusters of tests were performed at and the indicator cells were fed with fresh medium. After
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a total of 5 days, indicator cells were fixed, stained, and Immunization
syncytia were scored under 1001 magnification.
Two New Zealand White rabbits were each injected
intradermally with 18 mg of column-purified CA proteinConcentration of BLV virions
in Freund’s complete adjuvant. Three boosts were given
BLV-producing fetal lamb kidney cells (van der Maaten at 1-month intervals by subcutaneous injection of the
and Miller, 1976) and adherent cells isolated from same amount of antigen in Freund’s incomplete adjuvant.
PBMCs of sheep 169 (Radke et al., 1990) were propa- Beginning 3 months later, the rabbits were boosted three
gated in growth medium containing 2% fetal bovine se- more times with 15 mg gel-purified CA protein that was
rum. Supernatant harvested from cultures every 2 to 3 injected subcutaneously at 3-week intervals. Two weeks
days was cleared of cell debris by centrifugation at after the last boost, immunoblotting revealed that anti-
10,000 g for 30 min at 47 and then virions were pelleted CA antibodies were detectable in serum diluted as much
by centrifugation at 10,000 g for 16 hr at 47. After being as 1:8000 and the animals were terminally bled via heart
resuspended in cold buffer (10 mM Tris–HCl, pH 7.4, 1 puncture.
mM EDTA, 100 mM NaCl), pelleted material was layered
Immunocytochemistryover a 10–50% linear sucrose density gradient which
was centrifuged at 75,000 g for 4 hr at 47. Banded virions PBMCs (4 1 105 per sample) were deposited using a
were harvested and diluted with cold buffer to reduce cytocentrifuge onto slides coated with an 0.1 mg/ml solu-
sucrose to approximately 10% and then pelleted by cen- tion of poly-L-lysine (molecular weight, 70–150,000;
trifugation at 75,000 g for 1.5 hr at 47. Sigma). Cells were dried with a stream of cool air and
then fixed for 10 min with 4% paraformaldehyde in PBS
Purification of BLV CA protein containing 5 mM MgCl2 . After being rinsed with PBS,
slides were incubated in 100% acetone for 10 min atWe modified the procedure of Bex et al. (1979) to purify
room temperature and then rinsed again with PBS. CAboth the viral CA protein and the surface glycoprotein.
protein was optimally detected when primary antibodyConcentrated virions were disrupted by incubation in buf-
was applied without delay; both dry and wet storage offered detergent (10 mM Tris–HCl, pH 7.2, 1% w/v Triton
samples reduced the intensity of signal.X-100, 0.5 mM phenylmethylsulfonyl fluoride) for 15 min
Fixed cells were incubated for 15 min in blocking solu-on ice, and the lysate was centrifuged at 13,600 g for 3
tion (5% w/v nonfat dry milk suspended in 25 mM Tris–min to remove insoluble material. After dialysis against
HCl, pH 8.0, 150 mM NaCl, and 0.075% Tween 20) con-buffer (10 mM Tris–HCl, pH 7.2, 0.1% w/v Tween 80,
taining 10% fetal bovine serum. Primary antibodies, di-0.1 mM phenylmethylsulfonyl fluoride), the lysate was
luted 1:500 in blocking solution containing 5% goat se-applied to a DE-52 (Whatman) anion exchange column.
rum, were applied for 12 hr at 47 or for 2 hr at roomCA protein was eluted in the void volume, according to
temperature. After each incubation, slides were washedtwo criteria. After samples were electrophoresed in a
three times with the Tris–saline–Tween component of10% polyacrylamide gel containing SDS, silver staining
blocking solution. Biotinylated secondary goat antibodiesrevealed a band of protein migrating at 24,000 Da. It was
were diluted 1:100 in blocking solution and incubatedidentified as CA protein by immunoblotting (Radke et
with samples for 2 hr at room temperature. Biotinylatedal., 1990) using sera from BLV-infected sheep. Fractions
alkaline phosphatase complexed with avidin (Vectorcontaining CA protein were lyophilized and resolubilized
Labs) was added to washed samples for 1 hr. Positivein a minimal amount of water. Nonionic detergent was
cells were stained using the HistoMark Red substrateremoved from a portion by adsorption to Bio-Beads SM-
kit (Kirkegaard & Perry Laboratories) and cell nuclei were2 (Bio-Rad; Horigome and Sugano, 1983) so that the pro-
counterstained with 0.5% methyl green. CA-positive cellstein’s identity could be confirmed as CA by comparing
were counted using 20X and 40X planapochromat objec-its amino acid content and amino-terminal sequence
tives of a Nikon photomicroscope and the total number(Randolph et al., 1992) with those derived by Oroszlan et
of cells was determined for each cytodot to allow normal-al. (1979).
ization for sample size.To obtain protein to inject as antigen, 70 mg CA protein
from DE52 columns were electrophoresed on a prepara-
RESULTStive 10% polyacrylamide gel containing SDS. The gel was
placed in 4 M sodium acetate (Higgins and Dahmus,
LPS increased the number of BLV-infected PBMCs
1979) for 45 min to visualize the single, translucent band
synthesizing CA protein
migrating at approximately 24,000 Da. Acrylamide con-
taining CA protein was excised from the gel, soaked When PBMCs from BLV-infected sheep are cultured
briefly with LPS, the number of PBMCs transcribing BLVin water to reduce ionic strength, and homogenized in
phosphate-buffed saline (PBS: 1.5 mM KH2PO4 , 8 mM increases as well as the number of transcripts present
in each infected cell. We therefore asked whether LPSNa2HPO4 , 2.7 mM KCl, 140 mM NaCl; pH 7.4).
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similarly affects BLV protein synthesis using PBMCs ob- Several types of LPS increased BLV production
tained from the blood of sheep that had been experimen-
Having found that LPS increased infectious centerstally infected with BLV 1 to 4 years earlier. During the 4-
formation, we asked whether its microbial source wasmonth test period, all animals maintained individually
critical. Our standard LPS derived from S. minnesota wascharacteristic leukocyte profiles that fell within normal
tested together with LPS from S. typhimurium or Esche-ranges for percentage and absolute number of lympho-
richia coli, neither of which had stimulated BLV expres-cytes. PBMCs were tested several times by immunocyto-
sion in earlier studies (Djilali et al., 1987; Cornil et al.,chemical staining for the CA protein that is produced in
1988). When PBMCs from each of four animals werethe late stage of BLV expression (Powers and Radke,
cultured in the presence of 50 mg LPS per milliliter, all1992).
three types of LPS increased infectious centers to similarWhen cells were stained after 12 hr in culture, the
extents among cells from a given animal (Fig. 3).average basal number of CA-positive PBMCs in cultures
with no lymphocyte activator varied 11-fold among seven
Concentration dependence of LPS stimulation
different animals (Fig. 1A). LPS increased the number of
CA-positive PBMCs in each animal between 2.3- and 5- Since LPS was a good inducer of infectious centers
fold. Furthermore, staining of individual positive cells was at 50 mg per milliliter, a concentration commonly used
more intense after stimulation with LPS (not shown). The for B-cell mitogenesis, we asked whether lower concen-
number of CA-positive cells increased early and tran- trations could increase BLV production. PBMCs from two
siently during culture: a few were detectable as early as animals infected for 3 years displayed maximum levels
3 hr; the maximum number was present at 12 hr; and, of infectious centers at 10 mg LPS per milliliter (Table 1).
numbers were decreased by 20 hr and were further di- Similarly, when PBMCs from another animal (468) were
minished thereafter (Fig. 2). PBMCs from uninfected ani- tested for CA protein synthesis, the maximum number
mals did not stain for CA protein when cultured either was positive after being treated with 10 mg LPS per millili-
with or without LPS. Since PBMCs were evaluated after ter (Fig. 4).
only 12 hr in culture, BLV CA protein expression was
LPS increased infectious center formation throughoutassessed in cells that had a high probability of having
infectionbeen infected in vivo before secondary infection, subse-
quent integration, and expression might occur.
We wanted to know whether the ability of LPS to stimu-
late BLV production would be ongoing or whether it mightLPS increased the number of BLV-infected PBMCs
characterize a particular phase of infection in our sheep.acting as infectious centers
Additional measurements of infectious center activity in
When PBMCs from BLV-infected animals are cultured
its presence and absence revealed that LPS consistently
in medium containing fetal bovine serum, some of the
induced greater numbers of infected PBMCs to function
cells produce virus. Virus-producing cells can be enu-
as infectious centers (Fig. 5). Representative data are
merated by cocultivating them with adherent indicator
shown for one animal between 3 and 8 years after infec-
cells that become infected and form multinucleated syn-
tion, a period in which BLV infection was clinically
cytia 3 to 5 days later. Suspending the PBMCs in methyl-
asymptomatic. These data also demonstrate that the fre-
cellulose of low viscosity lets them settle onto the indica-
quency of circulating PBMCs producing BLV in culture
tor cells during cocultivation and increases the number
increased with time following initial infection, while the
that act as infectious centers (Radke et al., 1992). We
total number of PBMCs remained relatively constant.
therefore asked whether adding LPS into the methylcellu-
lose medium could stimulate even more infected PBMCs Comparison of PHA and LPS as stimulators of BLV
to register as infectious centers. CA synthesis and virus production
Cells from different animals varied 100-fold in the aver-
age basal number that scored as infectious centers in PHA has repeatedly been shown in previous studies
to increase BLV production whereas LPS has not, so wemethylcellulose medium with no lymphocyte activator
(Fig. 1B). Addition of 50 mg LPS per milliliter of methylcel- directly compared the effects of these two activators. For
cells collected between 1 and 4 years after infection,lulose medium increased the number of infectious cen-
ters between 2- and 4.4-fold. The ability of PBMCs to treatment of PBMCs with 5 mg PHA-P per milliliter did
not recruit BLV-infected cells to synthesize CA proteininitiate syncytium formation was maximal when they had
been cocultured with indicator cells for 14–21 hr (Fig. 2). as effectively as LPS had (Fig. 1A). However, positive
cells from PHA-treated cultures were stained even morePBMCs from uninfected animals did not induce syncytia
either with or without LPS. Furthermore, LPS did not in- intensely than those exposed to LPS (not shown). Thus,
LPS induced more infected PBMCs to synthesize CA pro-crease the capacity of cell-free BLV to induce syncytia
among the indicator cells (data not shown), so it ap- tein than PHA did, but PHA increased the amount of CA
protein synthesized in individual cells more than LPS did.peared to be acting directly on PBMCs.
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FIG. 1. LPS-stimulated CA protein synthesis and infectious center activity in PBMCs from BLV-infected sheep. Cells from each animal (identified
by number) were tested two to four times over a span of 4 months. (A) Synthesis of CA protein in PBMCs cultured for 12 hr in growth medium
containing no activator (N), PHA-P at 5 mg/ml (P), or LPS at 50 mg/ml (L). Immunocytochemical detection of CA protein was performed in duplicate;
cells from each animal were tested between one and five times. The average number of positive cells from each test was adjusted to a population
size of 2.5 1 105 PBMCs. The average number of CA-positive cells from all tests ({SEM) is plotted for each animal; animals are presented in order
of increasing effect of LPS. PBMCs were cocultured in duplicate with indicator cells (B) in methylcellulose growth medium to determine the number
acting as infectious centers and (C) in liquid medium to determine the number inducing syncytia. In both cases, media were supplemented as
described above during 48 hr of cocultivation and syncytia that developed among indicator cells were counted after 5 days. Plotted values represent
average numbers ({SEM) of PBMCs that acted as infectious centers or induced syncytia per 2.5 1 105 PBMCs.
Surprisingly, when PBMCs were treated with 5 mg PHA increased 2.1- to 3.3-fold relative to no-activator controls
for four of seven animals (Fig. 1C). This apparent changeper milliliter during coculture in methylcellulose medium,
the number that scored as infectious centers was the in PHA’s effect is attributable to the fact that fewer cells
from control cultures without activator scored as syncy-same as without activator (Fig. 1B), except for a marked
decrease among cells from one animal (409). LPS was tium inducers in liquid than in methylcellulose medium,
while numbers were approximately equal in the corre-a better inducer for cells from all animals. However, when
PBMCs were cultured in PHA-supplemented liquid me- sponding PHA-treated cultures. As was the case in meth-
ylcellulose medium, LPS induced large relative increasesdium lacking methylcellulose, syncytium formation was
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TABLE 1
Concentration of LPS Required to Elicit Maximal
Infectious Center Activity
Time after infection
Animal no. 3 years 4 years 5 years 6 years
167 — a 5b — 2.5
380 10 — — —
407 10 — 2.5 —
409 — — 5 —
410 — 5 — —
468 (10)c — 5 —
a —, not done.FIG. 2. Timing of BLV CA protein synthesis and initiation of syncytium
b mg LPS/ml.formation in culture. PBMCs obtained from animal 407 (d1210 after
c Concentration that elicited maximal CA protein synthesis.infection) were cultured in growth medium supplemented with 50 mg
LPS per milliliter. At the indicated times, cells were harvested, depos-
ited onto slides, and fixed. Immunocytochemical detection of CA protein
medium and proved to be a modest inducer in liquidwas performed in triplicate. Plots of CA-positive cells (l) represent
medium.average numbers ({SEM) of positives after adjusting the population
size to 2.5 1 105 PBMCs. In parallel, PBMCs (2.5 1 105 per sample) Attempts to optimize PHA-P showed that concentra-
were cocultured in duplicate in methylcellulose containing the same tions of up to 5 mg per milliliter yielded increasing num-
concentration of LPS. At the specified times, PBMCs were carefully bers of syncytia after PBMCs were treated overnight in
washed off the indicator cells. Numbers of infectious centers (s) repre-
cocultures in liquid medium (data not shown), but alsosent the average number ({SEM) of syncytia present after a total of 5
revealed that 5 mg per milliliter was ordinarily the highestdays.
usable concentration of this activator because growth of
indicator cells was frequently hindered in PHA-treated
in liquid medium, increasing syncytia 2.6- to 6.3-fold, so cocultures, an effect that was dependent on the presence
that it still acted as a better inducer than PHA. The abso- of PBMCs. However, in one successful test of higher
lute number of virus-producing cells was always largest concentrations of PHA, 10 mg per milliliter maximized
in methylcellulose medium containing LPS (Figs. 1B and syncytium induction and was as effective as 50 mg per
1C). Thus, in both methylcellulose and liquid medium, milliliter, the concentration used in a number of earlier
LPS increased the number of PBMCs that transmitted studies of BLV synthesis.
BLV to indicator cells relative to PBMCs supplemented PHA had to be used at 5 mg per milliliter for immunocy-
only with serum. In contrast, PHA conferred only a mini- tochemical staining of CA protein since higher concen-
mal increase in BLV-transmitting cells in methylcellulose trations aggregated cells into very large clumps that
could not be dispersed and flattened sufficiently for effec-
tive staining or microscopic observation. Even clumps
FIG. 4. LPS increased the number of PBMCs containing BLV CA
protein in a concentration-dependent manner. PBMCs obtained fromFIG. 3. LPS from three microorganisms increased infectious center
formation to similar extents. Cells from four animals were tested on animal 468 (d1202 after infection) were cultured for 12 hr in the pres-
ence of increasing concentrations of LPS or in its absence. After immu-different days by culturing PBMCs (2.5 1 105) in duplicate in methylcel-
lulose medium containing either no activator or LPS derived from S. nocytochemical staining of duplicate samples, CA-positive cells were
counted and their average numbers adjusted to a population size of 2.5minnesota (S.m.), S. typhimurium (S.t.), or E. coli O26:B6 (E.c.) at 50 mg/
ml. Relative numbers (rel. no.) of infectious centers represent average 1 105 PBMCs. Relative numbers (rel. no.) of CA-positive cells represent
average numbers obtained in the presence of LPS divided by averagenumbers of syncytia induced in the presence of LPS divided by average
numbers induced without activator. numbers obtained without activator.
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FIG. 5. LPS increased the number of PBMCs acting as infectious centers consistently throughout asymptomatic infection. PBMCs from animal
407 were cocultured with indicator cells in methylcellulose growth medium either with no activator (s) or with LPS (l). LPS was used at 50 mg/ml
through d1259, 25 mg/ml through d1309, and 10 mg/ml thereafter. Initially, 2.5 1 105 PBMCs were tested in each well but the number was gradually
reduced to 5 1 104 to compensate for the increasing frequency of positive cells. Numbers of infectious centers per microliter blood were obtained
by adjusting the averages of duplicate determinations to reflect the number of PBMCs (lymphocytes / monocytes) in 1 ml of blood on each date.
Arrows demarcate periods during which clustered tests of lymphocyte activators were performed as described in the text.
created by 5 mg PHA per milliliter were barely tractable, number of PBMCs synthesizing CA protein were equal to
or greater than those of LPS (Fig. 6). PBMCs from theso we could not test PHA at 50 mg per milliliter, a concen-
tration used by others in earlier studies. infected animals revealed two patterns of virus expres-
sion in PHA-treated cultures, one in which the number
of CA-positive cells continued to increase through 20 hr,PHA elicited CA synthesis more effectively than LPS
and another in which the increase lasted through 44 hr.as infection progressed
In contrast, the number of CA-positive PBMCs in LPS-
To determine whether LPS remained more effective treated cultures was maximal at 10 hr and remained
than PHA at stimulating BLV expression as asymptomatic constant or decreased thereafter. Secondary spread of
infection continued, we tested PBMCs from the five ani- BLV infection could in theory take place within 48 hr;
mals still alive 2 years after the original cluster of tests, however, culturing cells in the presence of dideoxycyti-
during an 8-month period. (For animal 407, the test period dine at 2 and 4 mM to inhibit reverse transcriptase activity
is demarcated by the middle set of arrows in Fig. 5.) At (Mitsuya and Broder, 1986) did not alter the number of
this time, the ability of PBMCs from animal 407 to act as CA-positive PBMCs in either LPS- or PHA-treated cul-
infectious centers was maximally stimulated by 2.5 mg tures (data not shown).
LPS per milliliter (Table 1), a quarter of the 10 mg per After 2 more years of asymptomatic infection, a third
milliliter required 2 years earlier. At 6 years after infec- cluster of tests was conducted on cells from the four
tion, PBMCs from animal 167 were maximally stimulated animals still alive. (For animal 407, the period is demar-
by half the concentration that had been required at 4 cated by the right most set of arrows in Fig. 5.) The ability
years after infection. Thus, the concentration of LPS re- of PHA to stimulate CA synthesis continued to increase
quired to elicit maximal infectious center formation de- whereas the level of LPS induction remained relatively
creased as infection progressed. constant with previous measurements or decreased for
In this cluster of tests, PHA was as effective or more both CA-positive PBMCs and infectious centers (Fig. 7).
effective than LPS at stimulating CA synthesis (Figs. 6 For logistic reasons, the second and third clusters of
measurements of CA-positive cells were made onand 7). By 10 hr in culture, PHA-mediated increases in the
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increases the amount of CA protein synthesized by indi-
vidual infected cells. These effects mirror those of LPS
on BLV transcription (Lagarias and Radke, 1989; Powers
and Radke, 1992) and indeed may primarily result from
the increased abundance of BLV transcripts. The LPS-
mediated increase in CA synthesis occurs early during
culture and its effect wanes overnight; this pattern also
characterizes transcription in both the presence and ab-
sence of LPS (Powers and Radke, 1992). Early stimulation
of BLV expression by LPS favors the ability of infected
PBMCs to transmit the virus to indicator cells in the infec-
tious center assay, an event that occurs within 14–21 hr
of initiating cocultures.
LPS probably delivers a direct, cell-autonomous signal
that positively regulates BLV expression. BLV transcrip-
tion increases as soon as 0.5–1 hr after PBMCs are
cultured with LPS and the increase is observed even
when protein synthesis is inhibited by cycloheximide
(Powers and Radke, 1992). Protein factors mediating
FIG. 6. LPS-mediated activation of CA protein synthesis was maximal transcription of immediate–early genes are activated in
early during culture, whereas PHA-mediated activation increased for the absence of protein synthesis, as for example is NF-
20 –44 hr. PBMCs were cultured for the indicated times in growth
kB, which is activated by LPS in B-cells (Muller et al.,
medium supplemented with no activator, 2.5 mg PHA-L per milliliter, or
1993). The BLV promoter has recently been shown to10 mg LPS per milliliter. CA-positive cells were counted after immunocy-
contain an NF-kB binding site (Brooks et al., 1995). Nei-tochemical staining; their numbers are expressed relative to the num-
ber of positive cells present at 10 hr without activator. The pattern of ther lymphokines produced by endogenously activated
expression for cells from animal 167 (top) was similar to that of animal T-cells nor cell–cell interactions are likely to have medi-
410 and the pattern for cells from animal 407 (bottom) was similar to ated the early, LPS-induced increase we observed in BLV
that of animals 409 and 468.
expression in these short-term cultures, since PBMCs
tested for CA protein were cultured at low density and
did not adhere to one another when treated with LPS.PBMCs harvested after 20 hr in culture. This may have
How LPS activates B-cells is unknown. No LPS recep-slightly diminished the relative increase obtained with
tor has been identified on the surface of B-cells althoughLPS, but did not alter the general pattern of diverging
several proteins are capable of binding LPS, includingresponses to the two inducers.
CD11c (Ingalls and Golenbock, 1995), an integrin nor-Thus, when the responses of PBMCs from the whole
mally found on myeloid cells but which is expressed by B-group of infected animals are examined as a function of
cells in cattle with BLV-induced persistent lymphocytosisthe duration of infection, expression of CA protein be-
(Matheise et al., 1992). LPS intercalates into the lipidcame more responsive to PHA but not to LPS (Fig. 7).
bilayer of B-cell plasma membranes (Printen et al., 1993),Infection eventually progressed to BLV-induced malig-
where it could function as a structural analog of lipidnancies in most of these animals: four developed tumors
second messengers such as diacylglycerol or ceramideat 6 years (410), 8 years (167, 468) and 9 years (407)
(Joseph et al., 1994). These second messengers activateafter infection; animal 409 died with a systemic bacterial
different isoforms of protein kinase C (Lozano et al.,infection after 8 years. (Animal 380 was euthanized after
1994), an enzyme that has been shown to play a role in4 years when it exhibited symptoms of paralysis and
mediating LPS effects on B-cells (reviewed by Bosca etanimal 469 developed tumors at 4 years.) PBMCs of tu-
al., 1991). Evidence that C kinase is involved in LPS-mor-bearing animals remained responsive to LPS al-
stimulated BLV expression has been presented by Jen-though the number of BLV-expressing PBMCs dropped
sen et al. (1992), who demonstrated that the kinase inhib-when the animals entered the terminal stage of disease.
itor 3-methyl H7 partially blocked an LPS-mediated in-
crease in synthesis of the BLV surface glycoprotein byDISCUSSION
PBMCs from infected cattle with persistent lymphocyto-
sis. Since inhibition was only partial, other mediators ofAs a polyclonal activator of B-lymphocytes, LPS would
be expected to affect the expression of a retrovirus the LPS effect are probably involved.
It is important to remember that LPS is most probablyadapted to exist in these cells. Our results show that
LPS stimulates increased numbers of PBMCs from BLV- a surrogate for a physiological inducer of BLV expression
in B-cells, since the concentrations of LPS used to stimu-infected sheep to synthesize the viral CA protein and
produce infectious virus in short-term cultures. LPS also late B-cells or BLV expression in culture far exceed those
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FIG. 7. Alteration in effects of PHA and LPS on BLV expression as infection progressed. Measurements of CA-positive PBMCs and infectious
center activity in methylcellulose medium were made on PBMCs at 2-year intervals after infection. At each interval, PBMCs from each animal were
tested four times over 4–8 months; relative increases in the number of positive cells conferred by each activator were determined for each test.
The average of these relative increases is plotted for each activator at each interval. Animals are presented in order of the LPS-mediated increase
in CA-positive cells. The cross indicates that sheep 167 died with a tumor 8 yr after infection. The increase in PHA-mediated stimulation of CA-
positive cells over time is significant (P  0.0004; significance of b1 in simple linear regression for all data points for all animals combined). The
decrease in LPS-mediated stimulation over time is not significant for either CA-positive cells (P  0.11) or infectious centers (P  0.13) by the same
test.
known to induce fatal endotoxic shock in sheep (Golen- PBMCs appeared to be more activated when they came
out of the animal’s circulation.bock et al., 1987). However, whereas concentrations of
micrograms per milliliter are required to elicit maximum The altered state of BLV host cells was also demon-
strated by their increasing response to PHA during thestimulation of B-cells, cytokine production by monocytes
is potently activated by picograms of LPS per milliliter. course of infection. PHA potentially could mediate sev-
eral different types of signaling events among BLV-in-Between 1 and 10% of the PBMCs in our low-density
cultures are monocytes; they conceivably could produce fected PBMCs in short-term cultures: those elicited in a
single cell, those dependent upon cell–cell interactions,tumor necrosis factor (TNF)-a that in turn could act on
B-cells. The rapidity of the LPS effect on early BLV tran- and those induced by diffusible lymphokines. Fluoro-
chrome-tagged PHA binds to the surface of immunoglob-scription argues against newly synthesized TNF-a acting
as a positive regulator at that step, but it could affect ulin M-positive sheep B-cells (K. Radke, unpublished re-
sults), so PHA potentially could cross-link surface glyco-later events in BLV replication.
Several observations indicate that the intrinsic ability proteins and induce a signaling pathway, albeit not one
leading to proliferation. We propose that such a cell-of BLV-infected cells to support BLV expression in culture
increased as asymptomatic infection progressed in autonomous effect of PHA was primarily responsible for
increasing expression of BLV CA protein within individualthese sheep. The basal number of cells that could ex-
press BLV without added activator increased while a cells at the outset of this study and for increasing BLV
transcripts present in PBMCs from the same sheep thatconstant or decreasing proportion of infected cells re-
sponded to LPS. Concurrently, lower concentrations of were tested during the preceding year (Lagarias and
Radke, 1989).LPS were required to elicit BLV expression by cells that
did respond to it. For example, PBMCs from animal 167 As infection progressed, PHA began to recruit more
cells to synthesize the viral CA protein than LPS did. Aswere maximally stimulated by 5 mg LPS per milliliter 4
years after infection, and by 2.5 mg per milliliter 6 years well as reflecting changes in the PHA-responsive path-
ways of infected cells, this phenomenon might have beenafter infection. Thus, as infection progressed, infected
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aided by the PHA-mediated clumping of virtually all increase our understanding of how BLV expression is
regulated in vivo.PBMCs in the cultures. Lymphokines produced by PHA-
stimulated T-cells could potently affect nearby B-cells
whereas dilution in culture medium and diffusion would
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